Indonesian digital pharmacy Lifepack scores $7M in Sequence A funding
Lifepack, a digital pharmacy in Indonesia, has raised $7 million in a Sequence A funding spherical led by Golden Gate Ventures.
Launched in 2020, the cellular well being platform gives high quality and low-cost medicines, together with over-the-counter medicine, common dietary supplements, and drugs for power sicknesses. Accessible on Android and iOS gadgets, Lifepack additionally offers on-demand on-line session from registered docs and a workforce of licensed pharmacists.
In accordance with a information report, its recent funds will go to constructing seven extra pharmacy warehouses throughout Indonesia, including to its present two warehouses in Jakarta and Surabaya.
CureApp indicators license take care of Sawai Group for upcoming NASH DTx app
Japanese medical know-how firm CureApp is getting an funding value as much as 10.5 billion yen ($77 million) as a part of a newly signed take care of the pharmaceutical agency Sawai Group.
The license settlement will present the Sawai Group unique rights for the event and advertising of a brand new digital therapeutics app for the remedy of non-alcoholic steatohepatitis (NASH), a complicated type of non-alcoholic fatty liver illness.
CureApp notes that there are some two million sufferers with NASH in Japan right this moment with 10 million extra who’re vulnerable to creating the illness.
Its upcoming DTx app will present customers with a personalised each day behaviour remedy routine and a visible information of their remedy standing.
The corporate plans to roll out the app in medical establishments by way of its proprietary app prescription service. Presently, CureApp is making ready to enter the third section of scientific trials of the NASH DTx app.
Wipro GE Healthcare ties up with Boston Scientific for mixed coronary heart care choices in India
Medical know-how firm Wipro GE Healthcare and Boston Scientific, a US-based medical gadget producer, have entered right into a collaboration to ship end-to-end interventional cardiac care options in India.
Boston Scientific will mix its medical gadgets with GE Healthcare’s medical imaging programs, significantly its cardiac catheterisation lab and associated software program, to help diagnostics by way of remedy and monitoring of the cardiac patient-care pathway.
The organisations may also help the coaching and schooling of healthcare professionals and can elevate client consciousness in regards to the improvements in cardiac catheterisation procedures.
The same collaboration that gives their mixed cardiology options has additionally kicked off in Southeast Asia.
Psychological well being app Mind helps Banyan Tree’s wellness programme
Digital psychological well being platform Mind has partnered with multinational hospitality group Banyan Tree to help the latter’s wellbeing programme.
Friends who’ve booked the Wellbeing Sanctuary service at Banyan Tree Bintan in Indonesia may have entry to the Mind cellular app as a part of an end-to-end wellbeing help bundle.
From August, guided content material and habit-building applications from the Mind app might be made accessible for visitors to entry all through and after their keep.
AstraZeneca to ship Alveofit’s IoT-powered spirometers throughout Indian care settings
AstraZeneca India has teamed up with digital respiratory care platform Alveofit to ship IoT-enabled spirometers throughout its community of care settings in India.
In accordance with a press assertion, the Alveofit gadgets might be used to remotely monitor the situations of sufferers with lung problems and related non-communicable ailments like bronchial asthma, pulmonary fibrosis and power obstructive pulmonary illness.
Will probably be distributed in choose hospitals beneath AstraZeneca’s A.Catalyst community, which incorporates Worker’s State Insurance coverage Corp. hospitals, command and army hospitals, common hospitals and final mile clinics in cities resembling Lucknow, Chennai, Nagpur, Delhi, Ahmedabad and Kolkata.